113 related articles for article (PubMed ID: 15026047)
1. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.
Suzuki K; Okawara T; Higashijima T; Yokomizo K; Mizushima T; Otsuka M
Bioorg Med Chem Lett; 2005 Apr; 15(8):2065-8. PubMed ID: 15808469
[TBL] [Abstract][Full Text] [Related]
3. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
4. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
5. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
6. Understanding topoisomerase I and II in terms of QSAR.
Verma RP
Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
[TBL] [Abstract][Full Text] [Related]
7. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
[TBL] [Abstract][Full Text] [Related]
8. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
[TBL] [Abstract][Full Text] [Related]
11. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.
Yakisich JS; Sidén A; Eneroth P; Cruz M
Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors.
Mizushina Y; Akihisa T; Ukiya M; Hamasaki Y; Murakami-Nakai C; Kuriyama I; Takeuchi T; Sugawara F; Yoshida H
Life Sci; 2005 Sep; 77(17):2127-40. PubMed ID: 15935396
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bis-benzimidazole derivatives with alkylating moiety.
Bielawski K; Wołczyński S; Bielawska A
Pol J Pharmacol; 2004; 56(3):373-8. PubMed ID: 15215569
[TBL] [Abstract][Full Text] [Related]
14. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.
Zhao LX; Moon YS; Basnet A; Kim EK; Jahng Y; Park JG; Jeong TC; Cho WJ; Choi SU; Lee CO; Lee SY; Lee CS; Lee ES
Bioorg Med Chem Lett; 2004 Mar; 14(5):1333-7. PubMed ID: 14980693
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis.
Lee YK; Seo CS; Lee CS; Lee KS; Kang SJ; Jahng Y; Chang HW; Son JK
Arch Pharm Res; 2009 Oct; 32(10):1409-15. PubMed ID: 19898804
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.
Cheng Y; An LK; Wu N; Wang XD; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Apr; 16(8):4617-25. PubMed ID: 18296054
[TBL] [Abstract][Full Text] [Related]
20. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]